Reprogrammed NK immune cells target cancer and autoimmune disorders
October 13, 2026
October 13, 2026
CAMBRIDGE, Massachusetts, Oct. 13 -- The Massachusetts Institute of Technology posted the following news:
* * *
Reprogrammed NK immune cells target cancer and autoimmune disorders
*
MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis.
Using their new technique, the resear . . .
* * *
Reprogrammed NK immune cells target cancer and autoimmune disorders
*
MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis.
Using their new technique, the resear . . .